The Cardiolevenator: Engineering the Optimal ESHF Treatment by Minimizing Occurrences of LVH скачать в хорошем качестве

The Cardiolevenator: Engineering the Optimal ESHF Treatment by Minimizing Occurrences of LVH

Alexa Spagnola, Aashka Patel, and Caroline Dowell-Esquivel analyzed the shortcomings of the current left ventricular assist device (LVAD) and designed the cardiolevenator, incorporating a unique drug-delivery system in order to prevent left ventricular hypertrophy/hypertrophic cardiomyopathy (LVH) from occurring due to excessive myocardial exertion. These are clips from my portion of a business proposal in Wellesley, MA. Patent is currently pending on design. Next step is experiment! EDIT: It's amazing to see how far I have come as a public speaker. This was one of my first experiences in front of a large audience, and I remember when that feeling of adrenaline came coursing through my veins thinking, "I have to do more of this." Sending love to Caroline now at Georgia Tech and Aashka at UMD!